Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Whitehawk Therapeutics Q3 EPS $(0.26) Misses $0.07 Estimate

Author: Benzinga Newsdesk | November 06, 2025 08:37am
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $0.07 by 488.06 percent. This is a 43.48 percent increase over losses of $(0.46) per share from the same period last year.

Posted In: WHWK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist